Edges in Network
Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | FOSL2 |
Upstream (Parents) |
---|
(<<) SALL1 → FOSL2 |
(<<) ESR1 → FOSL2 |
(<<) BHLHE41 → FOSL2 |
(<<) MMP14 → FOSL2 |
(<<) HOXB7 → FOSL2 |
(<<) TCF3 → FOSL2 |
(<<) HOXB6 → FOSL2 |
(<<) MAFF → FOSL2 |
(<<) FOS → FOSL2 |
(<<) PPARG → FOSL2 |
(<<) EVX1 → FOSL2 |
(<<) ZGPAT → FOSL2 |
(<<) PBX1 → FOSL2 |
(<<) CREB3L1 → FOSL2 |
(<<) TFEB → FOSL2 |
(<<) CEBPA → FOSL2 |
(<<) POU5F1B → FOSL2 |
(<<) KLF11 → FOSL2 |
Downstream (Children) |
---|
FOSL2 → FOXD1 (>>) |
FOSL2 → NEUROD1 (>>) |
FOSL2 → MYT1L (>>) |
FOSL2 → TP63 (>>) |
FOSL2 → NR2E3 (>>) |
FOSL2 → FOXO3 (>>) |
FOSL2 → TCF21 (>>) |
FOSL2 → LHX1 (>>) |
FOSL2 → NFIB (>>) |
FOSL2 → ALX3 (>>) |
FOSL2 → ETV2 (>>) |
FOSL2 → STAT2 (>>) |